Filing Flows › Pure Bioscience (PURE) › Q4 FY26 › vs Q3 FY26
Pure Bioscience (PURE) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Pure Bioscience's revenue rose $153K (+30%) from $506K in Q3 FY26 to $659K in Q4 FY26.
Pure Bioscience, Q4 FY26: revenue $659K (-14% year over year), operating margin -76.3%, net loss $610K, operating cash flow −$414K. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $659K | $506K | $153K | +30% |
| Net loss | $610K | $624K | −$14K | -2% |
| Costs & expenses | $1.3M | $1.1M | $139K | +12% |
| Operating costs | $1.2M | $1.0M | $138K | +13% |
| Interest & other, net | $107K | $106K | $1K | +0.9% |
| Cost of revenue | $290K | $237K | $53K | +22% |
| Research & development | $93K | $79K | $14K | +18% |
| SG&A | $779K | $708K | $71K | +10% |
| Operating cash sources | $610K | $624K | −$14K | -2% |
| Depreciation | $1K | $0 | $1K | — |
| Share-based compensation | $50K | $55K | −$5K | -9% |
| Working capital & other | $145K | $101K | $44K | +44% |
| Cash used in operations | $414K | $468K | −$54K | -12% |
| Net loss absorbed | $610K | $624K | −$14K | -2% |
Questions
How much did Pure Bioscience's revenue grow quarter over quarter in Q4 FY26?
Pure Bioscience's revenue rose $153K (+30%) from $506K in Q3 FY26 to $659K in Q4 FY26.